Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 646


Genomic assays for Epstein-Barr virus-positive gastric adenocarcinoma.

Gulley ML.

Exp Mol Med. 2015 Jan 23;47:e134. doi: 10.1038/emm.2014.93. Review.


Population-based cohort studies of type 2 diabetes and stomach cancer risk in Chinese men and women.

Xu HL, Tan YT, Epplein M, Li HL, Gao J, Gao YT, Zheng W, Shu XO, Xiang YB.

Cancer Sci. 2015 Mar;106(3):294-8. doi: 10.1111/cas.12597. Epub 2015 Jan 28.


Tumor-targeting Salmonella typhimurium A1-R decoys quiescent cancer cells to cycle as visualized by FUCCI imaging and become sensitive to chemotherapy.

Yano S, Zhang Y, Zhao M, Hiroshima Y, Miwa S, Uehara F, Kishimoto H, Tazawa H, Bouvet M, Fujiwara T, Hoffman RM.

Cell Cycle. 2014;13(24):3958-63. doi: 10.4161/15384101.2014.964115.


Preexisting oncogenic events impact trastuzumab sensitivity in ERBB2-amplified gastroesophageal adenocarcinoma.

Kim J, Fox C, Peng S, Pusung M, Pectasides E, Matthee E, Hong YS, Do IG, Jang J, Thorner AR, Van Hummelen P, Rustgi AK, Wong KK, Zhou Z, Tang P, Kim KM, Lee J, Bass AJ.

J Clin Invest. 2014 Dec;124(12):5145-58. doi: 10.1172/JCI75200. Epub 2014 Nov 17.


Src mutation induces acquired lapatinib resistance in ERBB2-amplified human gastroesophageal adenocarcinoma models.

Hong YS, Kim J, Pectasides E, Fox C, Hong SW, Ma Q, Wong GS, Peng S, Stachler MD, Thorner AR, Van Hummelen P, Bass AJ.

PLoS One. 2014 Oct 28;9(10):e109440. doi: 10.1371/journal.pone.0109440. eCollection 2014.


Single nucleotide polymorphisms of one-carbon metabolism and cancers of the esophagus, stomach, and liver in a Chinese population.

Chang SC, Chang PY, Butler B, Goldstein BY, Mu L, Cai L, You NC, Baecker A, Yu SZ, Heber D, Lu QY, Li L, Greenland S, Zhang ZF.

PLoS One. 2014 Oct 22;9(10):e109235. doi: 10.1371/journal.pone.0109235. eCollection 2014.


Metastatic tumor evolution and organoid modeling implicate TGFBR2 as a cancer driver in diffuse gastric cancer.

Nadauld LD, Garcia S, Natsoulis G, Bell JM, Miotke L, Hopmans ES, Xu H, Pai RK, Palm C, Regan JF, Chen H, Flaherty P, Ootani A, Zhang NR, Ford JM, Kuo CJ, Ji HP.

Genome Biol. 2014 Aug 27;15(8):428. doi: 10.1186/s13059-014-0428-9.


Thymidylate synthase genotype-directed chemotherapy for patients with gastric and gastroesophageal junction cancers.

Goff LW, Thakkar N, Du L, Chan E, Tan BR, Cardin DB, McLeod HL, Berlin JD, Zehnbauer B, Fournier C, Picus J, Wang-Gillam A, Lee W, Lockhart AC.

PLoS One. 2014 Sep 18;9(9):e107424. doi: 10.1371/journal.pone.0107424. eCollection 2014.


Biomarker testing for breast, lung, and gastroesophageal cancers at NCI designated cancer centers.

Schink JC, Trosman JR, Weldon CB, Siziopikou KP, Tsongalis GJ, Rademaker AW, Patel JD, Benson AB 3rd, Perez EA, Gradishar WJ.

J Natl Cancer Inst. 2014 Sep 12;106(10). pii: dju256. doi: 10.1093/jnci/dju256. Print 2014 Oct.


Single nucleotide polymorphisms in AREG and EREG are prognostic biomarkers in locally advanced gastric cancer patients after surgery with curative intent.

Wakatsuki T, Stintzing S, Zhang W, Yang D, Azuma M, Ning Y, Yamauchi S, Matsusaka S, Volz NB, Sunakawa Y, Koizumi W, Watanabe M, Barzi A, El Khoueiry AB, Shah MA, Lenz HJ.

Pharmacogenet Genomics. 2014 Nov;24(11):539-47. doi: 10.1097/FPC.0000000000000087.


Association between oral leukoplakia and upper gastrointestinal cancers: a 28-year follow-up study in the Linxian General Population Trial.

Fan JH, Wang JB, Qu CX, Zhang YQ, Taylor PR, Abnet CC, Dawsey SM, Qiao YL.

Oral Oncol. 2014 Oct;50(10):971-5. doi: 10.1016/j.oraloncology.2014.07.009. Epub 2014 Aug 11.


Bacterial CagA protein induces degradation of p53 protein in a p14ARF-dependent manner.

Wei J, Noto JM, Zaika E, Romero-Gallo J, Piazuelo MB, Schneider B, El-Rifai W, Correa P, Peek RM, Zaika AI.

Gut. 2015 Jul;64(7):1040-8. doi: 10.1136/gutjnl-2014-307295. Epub 2014 Jul 30.


Comprehensive molecular characterization of gastric adenocarcinoma.

Cancer Genome Atlas Research Network.

Nature. 2014 Sep 11;513(7517):202-9. doi: 10.1038/nature13480. Epub 2014 Jul 23.


RhoA mutations identified in diffuse gastric cancer.

Zhou J, Hayakawa Y, Wang TC, Bass AJ.

Cancer Cell. 2014 Jul 14;26(1):9-11. doi: 10.1016/j.ccr.2014.06.022.


Genetic mutation analysis of human gastric adenocarcinomas using ion torrent sequencing platform.

Xu Z, Huo X, Ye H, Tang C, Nandakumar V, Lou F, Zhang D, Dong H, Sun H, Jiang S, Zhang G, Liu Z, Dong Z, Guo B, He Y, Yan C, Wang L, Su Z, Li Y, Gu D, Zhang X, Wu X, Wei X, Hong L, Zhang Y, Yang J, Gong Y, Tang C, Jones L, Huang XF, Chen SY, Chen J.

PLoS One. 2014 Jul 15;9(7):e100442. doi: 10.1371/journal.pone.0100442. eCollection 2014.


TFF1 activates p53 through down-regulation of miR-504 in gastric cancer.

Soutto M, Chen Z, Saleh MA, Katsha A, Zhu S, Zaika A, Belkhiri A, El-Rifai W.

Oncotarget. 2014 Jul 30;5(14):5663-73.


Large-scale characterization of DNA methylation changes in human gastric carcinomas with and without metastasis.

Liu Z, Zhang J, Gao Y, Pei L, Zhou J, Gu L, Zhang L, Zhu B, Hattori N, Ji J, Yuasa Y, Kim W, Ushijima T, Shi H, Deng D.

Clin Cancer Res. 2014 Sep 1;20(17):4598-612. doi: 10.1158/1078-0432.CCR-13-3380. Epub 2014 Jul 9.


nc886, a non-coding RNA of anti-proliferative role, is suppressed by CpG DNA methylation in human gastric cancer.

Lee KS, Park JL, Lee K, Richardson LE, Johnson BH, Lee HS, Lee JS, Kim SB, Kwon OH, Song KS, Kim YS, Ashktorab H, Smoot DT, Jeon SH, Kim SY, Lee YS.

Oncotarget. 2014 Jun 15;5(11):3944-55.


Absolute quantitation of Met using mass spectrometry for clinical application: assay precision, stability, and correlation with MET gene amplification in FFPE tumor tissue.

Catenacci DV, Liao WL, Thyparambil S, Henderson L, Xu P, Zhao L, Rambo B, Hart J, Xiao SY, Bengali K, Uzzell J, Darfler M, Krizman DB, Cecchi F, Bottaro DP, Karrison T, Veenstra TD, Hembrough T, Burrows J.

PLoS One. 2014 Jul 1;9(7):e100586. doi: 10.1371/journal.pone.0100586. eCollection 2014.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk